These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23452406)

  • 1. Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration.
    Melville H; Carpiniello M; Hollis K; Staffaroni A; Golestaneh N
    J Transl Med; 2013 Mar; 11():53. PubMed ID: 23452406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration.
    Pennington BO; Clegg DO
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):261-71. PubMed ID: 26889704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Vitillo L; Tovell VE; Coffey P
    Curr Eye Res; 2020 Mar; 45(3):361-371. PubMed ID: 31777296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.
    Westenskow PD; Kurihara T; Friedlander M
    Adv Exp Med Biol; 2014; 801():323-9. PubMed ID: 24664714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell-derived retinal pigment epithelium transplantation for treatment of retinal disease.
    Nommiste B; Fynes K; Tovell VE; Ramsden C; da Cruz L; Coffey P
    Prog Brain Res; 2017; 231():225-244. PubMed ID: 28554398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal Pigment Epithelium Replacement Therapy for Age-Related Macular Degeneration: Are We There Yet?
    Sharma R; Bose D; Maminishkis A; Bharti K
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():553-572. PubMed ID: 31914900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
    O'Neill HC; Limnios IJ; Barnett NL
    Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
    Surendran H; Rathod RJ; Pal R
    Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.
    Artero-Castro A; Popelka S; Jendelova P; Motlik J; Ardan T; Rodriguez Jimenez FJ; Erceg S
    Expert Opin Drug Discov; 2019 Feb; 14(2):169-177. PubMed ID: 30616395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.
    Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M
    Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
    Sachdeva MM; Eliott D
    Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.
    Croze RH; Buchholz DE; Radeke MJ; Thi WJ; Hu Q; Coffey PJ; Clegg DO
    Stem Cells Transl Med; 2014 Sep; 3(9):1066-78. PubMed ID: 25069775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Based Therapies for Age-Related Macular Degeneration.
    Khateb S; Jha S; Bharti K; Banin E
    Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells: A therapeutic source for age-related macular degeneration.
    Parameswaran S; Krishnakumar S
    Indian J Ophthalmol; 2017 Mar; 65(3):177-183. PubMed ID: 28440245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
    Croze RH; Clegg DO
    Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell trials for macular degeneration: a preliminary report.
    Schwartz SD; Hubschman JP; Heilwell G; Franco-Cardenas V; Pan CK; Ostrick RM; Mickunas E; Gay R; Klimanskaya I; Lanza R
    Lancet; 2012 Feb; 379(9817):713-20. PubMed ID: 22281388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
    Singh MS; MacLaren RE
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular models and therapies for age-related macular degeneration.
    Forest DL; Johnson LV; Clegg DO
    Dis Model Mech; 2015 May; 8(5):421-7. PubMed ID: 26035859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.